Impact of HAART on HIV-linked malignancies

AIDS Read. 2003 May;13(5):202, 205.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active / methods*
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV-1
  • Humans
  • Immunocompromised Host* / drug effects
  • Immunocompromised Host* / immunology
  • Incidence
  • Lymphoma, Non-Hodgkin / epidemiology
  • Lymphoma, Non-Hodgkin / prevention & control
  • Lymphoma, Non-Hodgkin / virology
  • Male
  • Neoplasms / epidemiology
  • Neoplasms / prevention & control*
  • Neoplasms / virology*
  • Risk Factors
  • Sarcoma, Kaposi / epidemiology
  • Sarcoma, Kaposi / prevention & control
  • Sarcoma, Kaposi / virology
  • Treatment Outcome
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control
  • Uterine Cervical Neoplasms / virology